About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Urology
›
top-articles
Department of Urology
383
(top 1%)
papers
14.7K
(top 1%)
citations
69
(top 1%)
h
-index
102
(top 1%)
g
-index
417
all documents
15.7K
doc citations
2.7K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomy
Proceedings of the National Academy of Sciences of the United States of America
2009
378
2
Prevention and early detection of prostate cancer
Lancet Oncology, The
2014
372
3
Urinary Tract Infections in Children: EAU/ESPU Guidelines
European Urology
2015
298
4
Interleukin-6 regulation of prostate cancer cell growth
Journal of Cellular Biochemistry
2005
242
5
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
European Urology
2020
239
6
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
European Journal of Nuclear Medicine and Molecular Imaging
2015
234
7
Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
American Journal of Pathology
2012
225
8
Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
European Urology
2010
223
9
Alternative mechanisms of miR-34a regulation in cancer
Cell Death and Disease
2017
205
10
Androgen receptor signaling in prostate cancer
Cancer and Metastasis Reviews
2014
204
11
The Mutational Landscape of Prostate Cancer
European Urology
2013
203
12
Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
Molecular Cancer Therapeutics
2011
188
13
Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
Clinical Cancer Research
2012
188
14
JAK-STAT signaling in cancer: From cytokines to non-coding genome
Cytokine
2016
186
15
Adipose Tissue–derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor Growth
Molecular Therapy
2010
177
16
Targeted high throughput sequencing in clinical cancer Settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity
BMC Medical Genomics
2011
154
17
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review
Gerontology
2019
153
18
Interleukin‐6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival
International Journal of Cancer
2008
142
19
Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
Molecular and Cellular Endocrinology
2012
142
20
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor
Endocrine-Related Cancer
2009
141
21
Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography
BJU International
2008
139
22
Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway
Carcinogenesis
2012
137
23
STAT3 regulated ARF expression suppresses prostate cancer metastasis
Nature Communications
2015
136
24
Androgen Receptor Cross-talk with Cell Signalling Pathways
Growth Factors
2004
130
25
Expression and function of androgen receptor coactivators in prostate cancer
Journal of Steroid Biochemistry and Molecular Biology
2004
128
26
The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy
Clinical Cancer Research
2018
128
27
Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer
Oncotarget
2016
119
28
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer
Journal of Molecular Medicine
2013
117
29
Value of Real-Time Elastography Targeted Biopsy for Prostate Cancer Detection in Men With Prostate Specific Antigen 1.25 ng/ml or Greater and 4.00 ng/ml or Less
Journal of Urology
2010
114
30
ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
Frontiers in Molecular Biosciences
2020
112
31
Myoblast and Fibroblast Therapy for Post-Prostatectomy Urinary Incontinence: 1-Year Followup of 63 Patients
Journal of Urology
2008
106
32
Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
Immunology and Cell Biology
2010
103
33
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
Oncotarget
2016
103
34
Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
Endocrine-Related Cancer
2010
102
35
Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson’s disease in children
Journal of Hepatology
2007
100
36
The role of epithelial–mesenchymal transition drivers
ZEB
1 and
ZEB
2 in mediating docetaxel‐resistant prostate cancer
Molecular Oncology
2017
100
37
The anti‐interleukin‐6 antibody siltuximab down‐regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
Prostate
2011
99
38
Stem-Like Cells with Luminal Progenitor Phenotype Survive Castration in Human Prostate Cancer
Stem Cells
2012
98
39
α‐blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms
BJU International
2008
94
40
The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer
Journal of Pathology
2004
93
41
Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours
Journal of Steroid Biochemistry and Molecular Biology
2006
92
42
Expression and Prognostic Relevance of Annexin A3 in Prostate Cancer
European Urology
2008
91
43
Androgen axis in prostate cancer
Journal of Cellular Biochemistry
2006
90
44
Ultrasound of prostate cancer: recent advances
European Radiology
2008
90
45
Up-Regulation of Functional Chemokine Receptor CCR3 in Human Renal Cell Carcinoma
Clinical Cancer Research
2005
89
46
The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1
Oncogene
2007
89
47
EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment
Neurourology and Urodynamics
2020
88
48
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
Endocrine-Related Cancer
2005
86
49
EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205
British Journal of Cancer
2014
86
50
Interleukin-6 and prostate cancer: Current developments and unsolved questions
Molecular and Cellular Endocrinology
2018
86
site/software ©
exaly
; All materials licenced under
CC by-SA
.